9,10-dimethyl-1,2-benzanthracene and soblidotin

9,10-dimethyl-1,2-benzanthracene has been researched along with soblidotin in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Kobayashi, M; Natsume, T; Ogawa, K; Watanabe, J; Yasumura, K	1

Other Studies

1 other study(ies) available for 9,10-dimethyl-1,2-benzanthracene and soblidotin

Article	Year
Tumor-specific antivascular effect of TZT-1027 (Soblidotin) elucidated by magnetic resonance imaging and confocal laser scanning microscopy. Cancer science, 2007, Volume: 98, Issue:4 Topics: 9,10-Dimethyl-1,2-benzanthracene; Angiogenesis Inhibitors; Animals; Antineoplastic Agents; Breast Neoplasms; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Humans; Magnetic Resonance Imaging; Mammary Neoplasms, Experimental; Mice; Mice, Nude; Microscopy, Confocal; Oligopeptides; Rats; Rats, Nude; Tumor Cells, Cultured; Xenograft Model Antitumor Assays	2007

Article

Year

Tumor-specific antivascular effect of TZT-1027 (Soblidotin) elucidated by magnetic resonance imaging and confocal laser scanning microscopy.

Cancer science, 2007, Volume: 98, Issue:4

Topics: 9,10-Dimethyl-1,2-benzanthracene; Angiogenesis Inhibitors; Animals; Antineoplastic Agents; Breast Neoplasms; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Humans; Magnetic Resonance Imaging; Mammary Neoplasms, Experimental; Mice; Mice, Nude; Microscopy, Confocal; Oligopeptides; Rats; Rats, Nude; Tumor Cells, Cultured; Xenograft Model Antitumor Assays

2007